171 related articles for article (PubMed ID: 32097729)
1. ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells.
Xue DF; Pan ST; Huang G; Qiu JX
Int J Biochem Cell Biol; 2020 May; 122():105732. PubMed ID: 32097729
[TBL] [Abstract][Full Text] [Related]
2. Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma.
Xue D; Pan ST; Zhou X; Ye F; Zhou Q; Shi F; He F; Yu H; Qiu J
Oxid Med Cell Longev; 2020; 2020():5649174. PubMed ID: 32308804
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.
Liao JK; Zhou B; Zhuang XM; Zhuang PL; Zhang DM; Chen WL
Biomed Pharmacother; 2018 Jan; 97():1341-1348. PubMed ID: 29156523
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
[TBL] [Abstract][Full Text] [Related]
5. Glaucocalyxin A induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS.
Shi F; Xue D; Jiang Q; Qiu J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):235-246. PubMed ID: 33904969
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microRNA-17 enhances cisplatin-induced apoptosis of human tongue squamous carcinoma cell.
Sun Y; Nie W; Qiu B; Guo X; Zhang J; Wei J
J Bioenerg Biomembr; 2021 Apr; 53(2):169-176. PubMed ID: 33462751
[TBL] [Abstract][Full Text] [Related]
7. Bafilomycin A1 increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin by inhibiting the lysosomal uptake of platinum ions but not autophagy.
Chu HY; Wang W; Chen X; Jiang YE; Cheng R; Qi X; Zhong ZM; Zeng MS; Zhu XF; Sun CZ
Cancer Lett; 2018 Jun; 423():105-112. PubMed ID: 29524554
[TBL] [Abstract][Full Text] [Related]
8. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
9. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
10. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
Xue D; Zhou X; Qiu J
J Pharm Pharmacol; 2021 Mar; 73(1):98-109. PubMed ID: 33791802
[TBL] [Abstract][Full Text] [Related]
14. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.
Lv Z; Yang Y; Yang C
Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing.
Tian T; Lv X; Pan G; Lu Y; Chen W; He W; Lei X; Zhang H; Liu M; Sun S; Ou Z; Lin X; Cai L; He L; Tu Z; Wang X; Tannous BA; Ferrone S; Li J; Fan S
Clin Cancer Res; 2019 Jun; 25(12):3673-3688. PubMed ID: 30885939
[TBL] [Abstract][Full Text] [Related]
17. Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy.
Fernandez-Gil BI; Guerra-Librero A; Shen YQ; Florido J; Martínez-Ruiz L; García-López S; Adan C; Rodríguez-Santana C; Acuña-Castroviejo D; Quiñones-Hinojosa A; Fernández-Martínez J; Abdel Moneim AE; López LC; Rodríguez Ferrer JM; Escames G
Oxid Med Cell Longev; 2019; 2019():7187128. PubMed ID: 30944696
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.
Fan T; Pi H; Li M; Ren Z; He Z; Zhu F; Tian L; Tu M; Xie J; Liu M; Li Y; Tan M; Li G; Qing W; Reiter RJ; Yu Z; Wu H; Zhou Z
J Pineal Res; 2018 Mar; 64(2):. PubMed ID: 29149494
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway.
Yan X; Cao M; Wang Z; Wang S; Chen Q
Hum Cell; 2021 Sep; 34(5):1424-1433. PubMed ID: 34019244
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
